| Factor | 1-year mortality group | 1-year survival group | p value | ||
| (before TACE) | n = 32 | n = 64 | |||
| Age (years) | 71 | (56 - 86) | 71 | (41 - 87) | 0.669† |
| Sex (male/female) | 20/12 | 41/23 | 0.881§ | ||
| Height (cm) | 158.4 ± 8.0 | (144.0 - 174.5) | 161.0 ± 9.3 | (138.5 - 179.0) | 0.088* |
| Body weight (kg) | 62.1 | (48.0 - 91.5) | 59.8 | (37.0 - 93.6) | 0.280† |
| BMI (kg/m2) | 24.8 ± 2.7 | (19.0 - 30.0) | 22.9 ± 2.8 | (15.6 - 30.2) | 0.002* |
| HBs Ag (+/−) | 4/28 | 8/56 | 1.000¶ | ||
| HCV Ab (+/−) | 22/10 | 44/20 | 1.000§ | ||
| Alcohol (over 20 g/day) (+/−) | 9/23 | 22/42 | 0.537§ | ||
| Child's score (5, 6, 7, 8, 9) | 7 (5 - 9) | 6 (5 - 9) | 0.009† | ||
| MELD score | 7.3 (6.0 - 11.9) | 7.1 (6.0 - 20.7) | 0.465† | ||
| TNM stage of HCC (I, II, III, IVa, IVb) | 0/8/20/2/2 | 8/23/32/1 | 0.001* | ||
| Past treatment frequency of TACE (times) | 3 (0 - 11) | 1 (0 - 10) | 0.000† | ||
| Past treatments other than TACE (+/−) | 15/17 | 25/39 | 0.464§ | ||
| Visceral fat area (cm2/m2) | 39.9 (12.2 - 111.3) | 30.7 (2.3 - 93.0) | 0.016† | ||
| Subcutaneous and intermuscular fat area (cm2/m2) | 57.9 ± 20.9 (7.9 - 96.8) | 51.6 ± 24.2 (2.8 - 101.0) | 0.105* | ||
| Skeletal muscle area (cm2/m2) | 44.5 ± 6.9 (27.1 - 57.6) | 41.6 ± 8.6 (20.5 - 70.8) | 0.051* | ||
| PT (%) | 77.1 | (67.1 - 100.0) | 83.2 | (57.6 - 100.0) | 0.133† |
| AST (IU/L) | 47 | (19 - 165) | 49 | (18 - 141) | 0.920† |
| ALT (IU/L) | 35 | (11 - 111) | 37 | (13 - 130) | 0.388† |
| γ-GTP (IU/L) | 52 | (10 - 857) | 49 | (13 - 1188) | 0.594† |
| T-Bil (mg/dL) | 0.9 | (0.4 - 2.5) | 0.9 | (0.3 - 2.1) | 0.935† |
| ChE (IU/L) | 130 | (81 - 348) | 168 | (47 - 327) | 0.062† |
| Alb (g/dL) | 3.2 | (2.4 - 4.3) | 3.7 | (2.4 - 4.8) | 0.016† |
| Prealbumin (mg/dL) | 9.6 | (4.5 - 28.2) | 12.4 | (4.2 - 33.1) | 0.044† |
| BTR | 3.4 | (1.7 - 7.3) | 4.0 | (1.5 - 8.0) | 0.076† |
| CRP | 0.1 | (0.1 - 3.5) | 0.1 | (0.1 - 6.1) | 0.023† |
| Crn | 0.77 | (0.46 - 1.93) | 0.75 | (0.44 - 4.91) | 0.616† |
| FPG (mg/dL) | 100 | (71 - 207) | 101 | (74 - 351) | 0.834† |
| IRI (µU/mL) | 14 | (4 - 40) | 11 | (1 - 84) | 0.243† |
| HOMA-IR | 3.01 | (0.81 - 12.10) | 2.58 | (0.19 - 43.30) | 0.310† |
| HbA1c (%) | 5.3 | (4.4 - 6.9) | 5.4 | (4.3 - 10.2) | 0.112† |
| ICG test retention rate at 15 min (%) | 31.6 | (8.5 - 75.6) | 21.9 | (3.5 - 59.5) | 0.005† |
| Type 4 collagen 7S (ng/mL) | 7.3 | (5.0 - 11.0) | 6.5 | (3.0 - 16.0) | 0.091† |
| HA (ng/mL) | 286.9 | (53.8 - 1483.6) | 299 | (12.4 - 1237.8) | 0.841† |
| AFP (ng/mL) | 80 | (6 - 94260) | 17 | (2 - 14183) | 0.004† |
| DCP | 1249 | (16 - 688500) | 90 | (14 - 7138) | 0.000† |